PO.PS01.02 · 人群科学

埃塞俄比亚北部Ayder综合专科医院癌症患者的流行病学特征

Epidemiological characteristics of cancer patients at Ayder Comprehensive Specialized Hospital in Northern Ethiopia

编号 3555 展板 5 时间 4/20 02:00–05:00 区域 Section 34 主讲 Meley Atakilti, BS;MD
分会场 Cancer Surveillance: Emerging Cancer Trends and Population Differences
该海报暂无可下载的资料 AACR 官方页面

作者与单位 Authors & Affiliations

Meley Atakilti1, Desta Mulu2, Amanuel Asefa2, Dawit Zenebe3, Gebretsadik Lema4, Engda Hagos5

1Medicine, Patriots Healing Medical Center, Mekelle, Ethiopia,2Oncology, College of Health Science, Mekelle University, Mekelle, Ethiopia,3Epidemiology, College of Health Science, Mekelle University, Mekelle, Ethiopia,4Public Health, College of Health Science, Mekelle University, Mekelle, Ethiopia,5Biology, Colgate University, Hamilton, NY

摘要 Abstract

中文摘要
癌症是一项重大的全球公共卫生问题,在全球范围内导致高住院率和死亡率,然而针对东非尤其是埃塞俄比亚北部基于人群的癌症数据的研究却很有限。本研究描述了埃塞俄比亚提格雷州Ayder综合专科医院癌症的人口统计学、癌症类型等流行病学特征,评估了风险因素,并评价了治疗和预防方式,填补了该地区一项关键的信息空白。本研究采用回顾性描述性横断面设计,数据提取自医院癌症登记处及经确诊的癌症患者病历,时间跨度为2017年9月至2025年9月。关键变量包括年龄、性别、居住地、癌症类型、接受的治疗和生存状态。对数据进行了统计描述性分析。分析纳入4229例癌症患者。诊断时的中位年龄为46岁,63.2%的患者为女性。近44%的患者年龄在35至54岁之间。我们发现最常见的癌症为乳腺癌(12.7%)、宫颈癌(12.3%)、慢性髓性白血病(8.7%)、结直肠癌(7.5%)、卵巢癌(7%)和非霍奇金淋巴瘤(6.9%)。宫颈癌、乳腺癌和卵巢癌是女性中的主要癌症类型,而慢性髓性白血病、非霍奇金淋巴瘤和小/慢性淋巴细胞白血病则属于男性中的主要类型。在对女性乳腺癌患者的全面分析中,25%的患者年龄在40岁以下,最年轻者为19岁;近一半(45.3%)的结肠癌病例在50岁以下被诊断,最小者年仅8岁。此外,相当大比例的癌症病例(三分之二)出现在持续存在冲突的地区,提示可能存在环境风险因素暴露。本研究注意到年龄和性别存在显著差异。本研究呼吁扩大该地区的癌症登记站点。这些年龄组中的这些异常发现提示,有必要在该人群中筛查年轻个体的遗传易感性风险因素以及早期环境和生活方式暴露(提格雷是一个受冲突影响的地区,数十年来一直暴露于环境污染物)。该地区在这些高风险个体中缺乏分子检测(BRCA 1和2、TP53、MLH1和MSH2)及遗传风险评估,可能是一个促成因素。计划与实验室研究团队合作开展遗传风险评估,以进一步评价风险因素。迫切需要有针对性的更早筛查和管理策略,以尽量减轻该地区的癌症负担。
查看英文原文 English abstract
Cancer is a critical global public health issue, contributing to high rates of hospitalization and mortality worldwide yet limited research address population-based cancer data in East Africa particularly Northern Ethiopia. This study describes the epidemiology characteristics of cancer by demography, cancer type, and asses the risk factors and evaluates treatment and prevention modalities in Ayder Comprehensive Specialized Hospital, Tigray, Ethiopia filling a crucial information gap in the region. A retrospective descriptive cross-sectional study was employed, and data were extracted from hospital cancer registry and confirmed cancer patient's medical records spanning from September 2017 to September 2025. Key variables include age, sex, location, cancer type, treatment received and survival status. Statistical descriptive analysis was done across the data. The analysis includes 4229 cancer patients. Median age at diagnosis was 46 years and 63.2% of the patients were females. Nearly 44 % were aged 35 to 54. We found that the most common cancer was Breast (12.7%), Cervical (12.3%), Chronic Myeloid Leukemia (8.7%), colorectal cancer (7.5%), ovarian cancer (7%) and Non-Hodgkin Lymphoma (6.9%). While Cervical, Breast and Ovarian Cancer were the leading cancer types in females Chronic Myeloid Leukemia, Non-Hodgkin Lymphoma and Small/Chronic lymphocytic leukemia were among males. In a comprehensive analysis of female Breast cancer patients 25 % were under 40 years, the youngest being 19 and nearly half (45.3 %) of colonic cancer cases were diagnosed under 50 years of age, as young as 8 years old. In addition, a significant proportion of cancer cases (two third) were found in areas with ongoing conflict suggesting exposure to potential environmental risk factors. Significant variation in age and sex was noticed in this study . This study calls for expansion of cancer registry sites in the region. These unusual findings among these age groups suggest the need to screen the risk factors among young individuals for genetic predisposition and early environmental and lifestyle exposure in this population (Tigray is a conflict affected region with exposure to environmental contaminants for decades). The absence of molecular testing (BRCA 1 and 2, TP53, MLH1, and MSH2) and genetic risk assessment in those high-risk individuals in the region may be one contributing factor. In collaboration with laboratory research teams' genetic risk assessment is planned to further evaluate risk factors. Targeted earlier screening and management strategies are urgently needed to minimize cancer burden in this region.
利益披露 Disclosure
M. Atakilti, None.. D. Mulu, None.. A. Asefa, None.. D. Zenebe, None.. G. Lema, None.. E. Hagos, None.

← 返回 AACR 2026 检索